miR Scientific Presents Urine Based Test for Detecting Prostate and Bladder Cancer

miR Scientific LLC, a precision bioscience company focused on comprehensive disease detection and management, announced today a poster presentation at the 34th Annual European Association of Urology (EAU) Congress describing a key capability of its novel, non-invasive, unbiased biomarker Sentinel Scores™ disease management platform to identify clinically significant prostate cancer. The EAU, being held in Barcelona, Spain, draws more than 15,000 urology innovators from 100 countries.